share_log

424B3: Prospectus

424B3: Prospectus

424B3:募资说明书
美股SEC公告 ·  2024/12/31 10:45

Moomoo AI 已提取核心信息

Adial Pharmaceuticals has filed to register up to 5 million shares of common stock for resale by Alumni Capital LP. The shares include 68,807 commitment shares already issued and up to 4,931,193 additional shares that may be issued under a $5 million purchase agreement.The purchase agreement allows Adial to sell shares to Alumni Capital at 97% of the lowest daily VWAP over a 3-day period, subject to certain volume and price limitations. Proceeds will be used for strategic opportunities, working capital and general corporate purposes.The offering provides Adial with a flexible source of funding, but comes with risks of dilution for existing shareholders. The actual number of shares sold and proceeds received will depend on the company's capital needs and prevailing market conditions.
Adial Pharmaceuticals has filed to register up to 5 million shares of common stock for resale by Alumni Capital LP. The shares include 68,807 commitment shares already issued and up to 4,931,193 additional shares that may be issued under a $5 million purchase agreement.The purchase agreement allows Adial to sell shares to Alumni Capital at 97% of the lowest daily VWAP over a 3-day period, subject to certain volume and price limitations. Proceeds will be used for strategic opportunities, working capital and general corporate purposes.The offering provides Adial with a flexible source of funding, but comes with risks of dilution for existing shareholders. The actual number of shares sold and proceeds received will depend on the company's capital needs and prevailing market conditions.
Adial Pharmaceuticals 已申请注册最多 500万 股普通股以供 Alumni Capital LP 转售。这些股份包括已发行的 68,807 股承诺股份以及可能根据 500万 购股协议再发行的最多 4,931,193 股。购股协议允许 Adial 以低于 3 天周期内最低日加权平均价 (VWAP) 的97% 向 Alumni Capital 出售股份,但须遵守某些成交量和价格限制。募集的资金将用于战略机会、营运资金和一般公司用途。此次发行为 Adial 提供了一种灵活的资金来源,但也带来了现有股东的稀释风险。实际出售的股份数量和获得的收益将取决于公司的资本需求和市场状况。
Adial Pharmaceuticals 已申请注册最多 500万 股普通股以供 Alumni Capital LP 转售。这些股份包括已发行的 68,807 股承诺股份以及可能根据 500万 购股协议再发行的最多 4,931,193 股。购股协议允许 Adial 以低于 3 天周期内最低日加权平均价 (VWAP) 的97% 向 Alumni Capital 出售股份,但须遵守某些成交量和价格限制。募集的资金将用于战略机会、营运资金和一般公司用途。此次发行为 Adial 提供了一种灵活的资金来源,但也带来了现有股东的稀释风险。实际出售的股份数量和获得的收益将取决于公司的资本需求和市场状况。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息